Teva Will Appeal Patent Ruling On P&G's Actonel
Teva Pharmaceutical Industries Ltd. will appeal a Delaware federal court's decision, which found that the generics drugmaker infringed a Procter & Gamble patent for osteoporosis drug Actonel....To view the full article, register now.
Already a subscriber? Click here to view full article